Esimerkkejä Contents of the vial käytöstä Englanti ja niiden käännökset Suomi
{-}
-
Medicine
-
Colloquial
-
Official
-
Financial
-
Ecclesiastic
-
Official/political
-
Computer
-
Programming
Inject the entire contents of the vial.
Inject the entire contents of the vial.
Withdraw the entire contents of the vial.
Inspect the contents of the vials for particulate matter and discolouration.
It is important to withdraw the entire contents of the vial.
Inspect the contents of the vials for particulate matter and discolouration.
If the solvent does not completely transfer into the BeneFIX vial, DO NOT USE the contents of the vial.
If someone went so far as to touch the contents of the vial, that… That would not be good.
Once mixed, the contents of the vial should appear a pink/red or yellowish colour with a slight opalescence.
With the other hand, slowly pull the syringe plunger down to withdraw the full contents of the vial 1 ml.
Draw up the entire contents of the vial containing Foscan into a syringe and expel air Figure 1.
Since Mozobil is supplied as a sterile, preservative-free formulation, aseptic technique should be followed when transferring the contents of the vial to a suitable syringe for subcutaneous administration see section 6.3.
A hospital pharmacist, nurse or doctor will have diluted the contents of the vial with sodium chloride 9 mg/ml(0.9%) solution before use.
Reconstitute the contents of the vial with 1.2 mL of sterile water for injection preferably using a 2 to 3 mL syringe and a 21G needle.
To prepare the working solution of the drug Xulat Micro, the contents of the vial(30 ml) are dissolved in 3 liters of water and thoroughly mixed.
Ensure that the contents of the vial are fully dissolved and the reconstituted material is a clear, colourless to pale yellow solution.
Immediately prior to use, contents of the vial are reconstituted in the unlabeled form to prepare LeukoScan 99mTc.
Contents of the vial are intended only for use in the preparation and radiolabelling of Lymphoseek and are not to be administered directly to the patient without first undergoing the preparative procedure.
Before activation(shaking) the contents of the vial, Luminity appears as a colourless, uniformly clear to translucent liquid.
Contents of the vial are intended only for use in the preparation of technetium(99mTc) besilesomab and are not to be administered directly to the patient without first undergoing the preparative procedure.
For this purpose, the contents of the vials are to be added to 500 ml isotonic sodium chloride solution(or 500 ml 5% dextrose solution) and infused over two hours.
Dilute the content of the vial with clean room temperature water into an appropriate container.
Mixing is continued until the content of the vial is completely dissolved and is free of particulate matter by visual inspection.
Once the content of the vials has been mixed together the resulting liposomal dispersion is orange-red and opaque.